Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover

I. Hamad, A.C. Hunter, Ken Rutt, Z. Liu, H. Dai, S.M. Moghimi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology